Table 2 Clinicopathologic information.
Gender | Average Age | Tissue Sample | Clinicopathology | Metastasis/ Recurrence | Anatomical Location | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Male | 179 | 66.54 ± 11.72 | Normal | 31 | Pathologic Stage II | 42 | M0 | 65 | Cecum | 5 |
| Â | Â | Â | Adenoma | 27 | Â | Â | M1 | 9 | Ascending Colon | 4 |
| Â | Â | Â | CRC | 121 | Â | Â | Recurrence | 8 | Transverse Colon | 8 |
| Â | Â | Â | Â | Â | Â | Â | Â | Â | Descending Colon | 1 |
| Â | Â | Â | Â | Â | Â | Â | Â | Â | Sigmoid | 21 |
| Â | Â | Â | Â | Â | Â | Â | Â | Â | Rectosigmoid | 1 |
| Â | Â | Â | Â | Â | Â | Â | Â | Â | Rectum | 11 |
Female | 194 | 66.19 ± 11.20 | Normal | 51 | Pathologic Stage II | 48 | M0 | 58 | Cecum | 4 |
| Â | Â | Â | Adenoma | 23 | Â | Â | M1 | 9 | Ascending Colon | 9 |
| Â | Â | Â | CRC | 120 | Â | Â | Recurrence | 10 | Transverse Colon | 1 |
| Â | Â | Â | Â | Â | Â | Â | Â | Â | Descending Colon | 7 |
| Â | Â | Â | Â | Â | Â | Â | Â | Â | Sigmoid | 21 |
| Â | Â | Â | Â | Â | Â | Â | Â | Â | Rectosigmoid | 1 |
| Â | Â | Â | Â | Â | Â | Â | Â | Â | Rectum | 11 |
Unidentified | 332 | n/a | Normal | 149 | Low Grade Polyp Dysplasia | 16 | M0 | 68 | Cecum | 0 |
| Â | Â | Â | Adenoma | 82 | High Grade Polyp Dysplasia | 13 | M1 | 18 | Ascending Colon | 8 |
| Â | Â | Â | CRC | 101 | Dukes A/B | 14 | Recurrence | 26 | Transverse Colon | 2 |
| Â | Â | Â | Â | Â | Pathologic Stage I | 10 | Â | Â | Descending Colon | 8 |
| Â | Â | Â | Â | Â | Pathologic Stage II | 37 | Â | Â | Sigmoid | 32 |
| Â | Â | Â | Â | Â | Pathologic Stage III | 23 | Â | Â | Rectosigmoid | 0 |
| Â | Â | Â | Â | Â | Pathologic Stage IV | 18 | Â | Â | Rectum | 14 |